CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 5001 - 5025 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C60505 Cell clone integrant comprise 20 percent clone population indicator

Indicator of whether any cell clone(s) or integrant(s) comprise >=20 percent of all clones.

Supplemental 1.00 2021-04-22 14:36:37.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60506 Clone integrant minimum 20 percent representation integration site gene location

Location of the integration site (gene or flanking gene) of clone(s) or integrant(s) having >=20 percent representation in the clone population.

Supplemental 1.00 2021-04-22 14:42:22.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60507 Clone integrant minimum 20 percent representation value

Value, as a percentage, of the representation among all clones/integrants of the clones/integrants at the specified gene or flanking gene location, for clones/integrants comprising >=20 percent of all clones/integrants.

Supplemental 1.00 2021-04-22 14:46:13.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60508 Clone integrant minimum 20 percent representation genetic location

Location, relative to other genes on a DNA strand, of any clone(s) or integrant(s) having >=20 percent representation within the population of clones and integrants.

Supplemental 1.00 2021-04-22 16:30:50.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60509 Insertional oncogene near clone integrant minimum 20 percent representation name

Name(s) of the gene(s) associated with insertional oncogenesis within or near which are located clone(s) or integrant(s) that have >=20 percent representation among the population of all clones and integrants.

Supplemental 1.00 2021-04-22 16:41:29.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60510 Cell clone proportional increase last two analysis indicator

Indicator of whether any cell clones have increased in proportion over the last two analyses.

Supplemental 1.00 2021-04-22 16:49:24.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60511 Cell clone proportional increase last two analysis identifier text

Text field for identifying cell clone(s) that have increased as a proportion of the population of clones over the last two analyses.

Supplemental 1.00 2021-04-22 16:51:48.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60512 Cell clone proportional increase last two analysis previous proportion percent value

Value as a percent of the proportion of all cell clones, that the specified cell clone showing proportional increase over the last two analyses presented during the previous analysis.

Supplemental 1.00 2021-04-22 16:53:58.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60513 Cell clone proportional increase last two analysis current proportion percent value

Value as a percent of the proportion of all cell clones, that the specified cell clone showing proportional increase over the last two analyses presented during the current (i.e., most recent) analysis.

Supplemental 1.00 2021-04-22 16:53:58.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60514 Gene modified hematopoiesis best characterize type

Type of condition that best characterizes the observed gene-modified hematopoiesis.

Supplemental 1.00 2021-04-23 10:54:46.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60515 Gene edit frequency text

Text field for capturing the frequency with which gene editing was performed.

Supplemental 1.00 2021-04-23 11:03:20.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60517 Gene edited hematopoietic stem progenitor cells blood CD3 depleted conversion percent value

Value of the percentage of conversions related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood.

Supplemental 1.00 2021-04-23 11:09:53.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60518 Gene edited hematopoietic stem progenitor cells blood CD3 depleted on target indel count

Count of on-target indels related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood.

Supplemental 1.00 2021-04-23 11:12:55.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60527 Gene editing blood GPA plus lineage on target indel count

Count of gene-editing on-target indels in the blood GPA+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60522 Gene editing conversion blood GPA plus lineage percent value

Value of the percentage of gene-editing conversions in the blood GPA+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60642 Gene editing blood CD3 plus lineage off target indel count

Count of gene-editing off-target indels in the blood CD3+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60519 Gene editing conversion blood CD3 plus lineage percent value

Value of the percentage of gene-editing conversions in the blood CD3+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60520 Gene editing conversion blood CD19 plus lineage percent value

Value of the percentage of gene-editing conversions in the blood CD19+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60528 Gene editing blood CD14 plus lineage on target indel count

Count of gene-editing on-target indels in the blood CD14+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60523 Gene editing conversion blood CD14 plus lineage percent value

Value of the percentage of gene-editing conversions in the blood CD14+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60643 Gene editing blood CD19 plus lineage off target indel count

Count of gene-editing off-target indels in the blood CD19+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60521 Gene editing conversion blood CD15 plus lineage percent value

Value of the percentage of gene-editing conversions in the blood CD15+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60524 Gene editing blood CD3 plus lineage on target indel count

Count of gene-editing on-target indels in the blood CD3+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60644 Gene editing blood CD15 plus lineage off target indel count

Count of gene-editing off-target indels in the blood CD15+ lineage.

Core 1.00 2021-04-23 11:20:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60522 Gene editing conversion blood GPA plus lineage percent value

Value of the percentage of gene-editing conversions in the blood GPA+ lineage.

Supplemental 1.00 2021-04-23 11:20:12.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
Displaying 5001 - 5025 of 5231